PI3K inhibitors may promote cancer spreadJuly 4, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
PI3Kδ/γ inhibitor generates rapid responses in CLLJuly 2, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Drug can produce durable responses in rel/ref PTCLJuly 1, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Team endorses intensified chemo for PET-positive HLJune 30, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
‘Radically different’ PI3Kδ inhibitor lacks hepatotoxicityJune 30, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin Lymphoma
Insecticide can cause NHL, experts sayJune 29, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Nivolumab produces ‘dramatic’ responses in HLJune 25, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Targeted agent shows early promise for NHLJune 25, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
EZH2 inhibitor proves active in rel/ref NHLJune 23, 2015Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Bleomycin can be safely omitted after negative PET2 in HLJune 23, 2015Lymphoma & Plasma Cell DisordersHodgkin Lymphoma
Combo delays progression in relapsed CLLJune 19, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Viral protein protects EBV-infected B cellsJune 14, 2015Lymphoma & Plasma Cell DisordersRelated Issues
Harnessing immune defense to treat Candida infectionJune 11, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated IssuesTransplantation
CAR T-cell therapy seems feasible for NHL, MMJune 11, 2015Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin Lymphoma
